Opus Genetics

(NASDAQ) IRD

Current Price$5.14

Market Cap$367.01M

Since IPO (2020)-14%

5 Year+1%

1 Year+448%

1 Month+10%

Opus Genetics Financials at a Glance

Market Cap

$367.01M

Revenue (TTM)

$14.20M

Net Income (TTM)

$49.59M

EPS (TTM)

$-0.84

P/E Ratio

-6.10

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$5.14

Volume

676,633

Open

$5.13

Price

$5.14

Volume

676,633

Open

$5.13

Previous Close

$5.14

Daily Range

$5.02 - $5.21

52-Week Range

$0.90 - $5.81

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$5.14

Volume

676,633

Open

$5.13

Previous Close

$5.14

Daily Range

$5.02 - $5.21

52-Week Range

$0.90 - $5.81

IRD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Opus Genetics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

George Magrath, III, MD

Website

opusgtx.com

Headquarters

Durham, MI 48335, US

IRD Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-449%

Return on Capital

-91%

Return on Assets

-99%

Earnings Yield

-16.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$367.01M

Shares Outstanding

71.40M

Volume

676.63K

Avg. Volume

967.26K

Financials (TTM)

Gross Profit

$14.14M

Operating Income

$38.60M

EBITDA

$38.60M

Operating Cash Flow

$35.25M

Capital Expenditure

$0.00

Free Cash Flow

$35.25M

Cash & ST Invst.

$45.09M

Total Debt

$0.00

Opus Genetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$3.87M

-10.2%

Gross Profit

$3.85M

+210.8%

Gross Margin

99.66%

N/A

Market Cap

$367.01M

N/A

Market Cap/Employee

$20.39M

N/A

Employees

N/A

Net Income

$16.52M

+53.0%

EBITDA

$11.44M

-14.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$45.09M

+48.7%

Accounts Receivable

$3.17M

-45.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-98.70%

N/A

Return on Invested Capital

-90.90%

N/A

Free Cash Flow

$9.83M

-32.2%

Operating Cash Flow

$9.83M

-32.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALECAlector, Inc.

ALECAlector, Inc.$2.36-0.42%

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.33+4.02%

AGENAgenus Inc.

AGENAgenus Inc.$3.84-1.79%

ABOSAcumen Pharmaceuticals, Inc.

ABOSAcumen Pharmaceuticals, Inc.$2.38-0.42%

SEERSeer, Inc.

SEERSeer, Inc.$2.03+4.10%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.28+1.59%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.61+3.26%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About IRD

What is the current price of Opus Genetics?

Opus Genetics is trading at $5.14 per share.

What is the 52-week range for Opus Genetics?

Over the past 52 weeks, Opus Genetics has traded between $0.90 and $5.81.

How much debt does Opus Genetics have?

As of the most recent reporting period, Opus Genetics reported total debt of $1.13M.

How much cash does Opus Genetics have on hand?

Opus Genetics reported $45.09M in cash and cash equivalents in its most recent financial results.

What is Opus Genetics’s dividend yield?

Opus Genetics does not currently have a dividend yield.

Opus Genetics

Opus Genetics Financials at a Glance

IRD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Opus Genetics

IRD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Opus Genetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IRD

What is the current price of Opus Genetics?

What is the 52-week range for Opus Genetics?

How much debt does Opus Genetics have?

How much cash does Opus Genetics have on hand?

What is Opus Genetics’s dividend yield?

Premium Investing Services